In addition, there was no significant difference in the incidence of pneumocystis pneumonia between the two groups, although it has been shown that TNF inhibitors increase the incidence of opportunistic infections including pneumocystis pneumonia and tuberculosis in RA patients [20–22]. Here, TNF is linked to rheumatoid arthritis.